# Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial

> **NCT00211692** · PHASE3 · COMPLETED · sponsor: **Minneapolis Veterans Affairs Medical Center** · enrollment: 64 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** consensus interferon (Interferon Alfacon-1) and ribavirin
- **DRUG:** Consensus Interferon alfa (CIFN) and ribavirin

## Key facts

- **NCT ID:** NCT00211692
- **Lead sponsor:** Minneapolis Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-07
- **Final completion:** 2009-09
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2014-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211692, "Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00211692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*